drugset / Trial / NCT00482001

Impact of Cholinesterase Inhibitors on Driving Ability in Healthy Older Adults

NCT00482001

RandomizedParallel-groupQuadruple-blindSupportive care

Summary

The goal of the study is to assess the role of cholinesterase inhibitors in affecting the driving ability of cognitively intact seniors using driving simulators. We hypothesize that the use of a cholinesterase inhibitor for two weeks will be associated with improvement in safe driving behavior on a simulated driving task.

Timeline

Start
2007-06
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Donepezil Small molecule 5 mg

Indications